Los Angeles Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$869K Buy
1,211,155
+523,368
+76% +$375K ﹤0.01% 688
2025
Q1
$1.01M Buy
687,787
+356,087
+107% +$523K ﹤0.01% 564
2024
Q4
$1.47M Buy
331,700
+319,528
+2,625% +$1.42M 0.01% 509
2024
Q3
$50.1K Sell
12,172
-24,674
-67% -$102K ﹤0.01% 1150
2024
Q2
$240K Sell
36,846
-48,497
-57% -$316K ﹤0.01% 1083
2024
Q1
$743K Buy
85,343
+57,806
+210% +$503K ﹤0.01% 774
2023
Q4
$315K Sell
27,537
-22,978
-45% -$263K ﹤0.01% 1006
2023
Q3
$486K Sell
50,515
-164,146
-76% -$1.58M ﹤0.01% 830
2023
Q2
$2.28M Buy
214,661
+22,105
+11% +$235K 0.01% 461
2023
Q1
$2.03M Sell
192,556
-8,789
-4% -$92.5K 0.01% 498
2022
Q4
$2.49M Buy
201,345
+48,037
+31% +$595K 0.01% 463
2022
Q3
$1.59M Buy
153,308
+93,835
+158% +$972K 0.01% 563
2022
Q2
$686K Hold
59,473
﹤0.01% 851
2022
Q1
$748K Hold
59,473
﹤0.01% 875
2021
Q4
$693K Sell
59,473
-674
-1% -$7.85K ﹤0.01% 863
2021
Q3
$786K Buy
60,147
+2,360
+4% +$30.8K ﹤0.01% 856
2021
Q2
$744K Sell
57,787
-3,255
-5% -$41.9K ﹤0.01% 992
2021
Q1
$682K Sell
61,042
-81,300
-57% -$908K ﹤0.01% 1079
2020
Q4
$1.62M Sell
142,342
-898
-0.6% -$10.2K 0.01% 738
2020
Q3
$1.29M Sell
143,240
-14,018
-9% -$126K 0.01% 725
2020
Q2
$1.62M Buy
157,258
+5,482
+4% +$56.6K 0.01% 680
2020
Q1
$1.53M Buy
151,776
+29,095
+24% +$293K 0.01% 608
2019
Q4
$1.63M Buy
122,681
+45,584
+59% +$607K 0.01% 698
2019
Q3
$662K Hold
77,097
﹤0.01% 912
2019
Q2
$843K Buy
77,097
+14,111
+22% +$154K ﹤0.01% 892
2019
Q1
$714K Buy
+62,986
New +$714K ﹤0.01% 975
2018
Q3
Sell
-19,480
Closed -$312K 1431
2018
Q2
$312K Sell
19,480
-30,811
-61% -$493K ﹤0.01% 1274
2018
Q1
$650K Buy
+50,291
New +$650K ﹤0.01% 954